From the journal of Biotech & Genetic Engineering:

The results of an open-label pilot study have found that treating patients with an advanced form of age-related macular degeneration (AMD) using the Parkinson’s disease drug, levodopa, stabilized their disease and improved vision. The study demonstrated that oral levodopa therapy was safe and well-tolerated, and reduced the need for patients with neovascular AMD (nAMD) to receive anti-VEGF injections.

Short version: the same drug which seemed to help macular degeneration (MD) patients, also seems to help those with Parkinson’s disease. How much it helps remains to be seen, but further studies are in the works.

Brought to you by smpltec.com, Technology for Seniors News.